GW Cancer Center Launches Online Community of Practice for Patient-centered Care

September 12, 2016

WASHINGTON (Sept. 12, 2016) - The George Washington University (GW) Cancer Center is pleased to announce the launch of the first-ever online Community of Practice for patient-centered cancer care. Supported by the Patient-Centered Outcomes Research Institute (PCORI) through a $250,000 Eugene Washington PCORI Engagement Award, the GW Cancer Center built on existing dissemination efforts to develop an online site called the Generation and Translation of Evidence (GATE). The GATE is an engagement and communication mechanism that initially will focus on cancer patient navigation and cancer survivorship.

“The GATE represents a new way of doing research that is highly collaborative and engages stakeholders from conceptualization to dissemination," said Mandi Pratt-Chapman, associate center director for patient-centered initiatives and health equity for the GW Cancer Center. “Through this Community of Practice, we bring together researchers, front-line clinicians, and the patients who should benefit from our research endeavors to improve the relevance and reach of our research."

In addition to fostering collaboration among the patient-centered research community, GATE will help shepherd research into practice more quickly.

“In bringing together diverse stakeholders-clinicians, patients and researchers-the GATE will help to reduce the on-average 17-year lag between research discoveries and practice implementation," said Sarah Birken, Ph.D., co-chair for the survivorship special interest group for the GATE project and assistant professor in the Department of Health Policy and Management in the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill. “Collaboration across sectors will speed the implementation of state-of-the-art survivorship care practices."

The GATE includes the following components:

  • research findings,
  • practice-based insights and lessons learned,
  • searchable questions-and-answers,
  • ask the expert small group sessions,
  • special interest groups, and
  • an e-newsletter

“The GATE Cancer Community of Practice fills a need for quality, relevant information for patients and other stakeholders and provides a launching pad for implementing promising evidence-based practices and programs," said Jean Slustsky, chief engagement and dissemination officer at PCORI.

PCORI is an independent, non-profit organization authorized by Congress in 2010 to fund comparative effectiveness research that will provide patients, their caregivers, and clinicians with the evidence needed to make better-informed health and healthcare decisions. PCORI is committed to seeking input from a broad range of stakeholders to guide its work.

Media: To interview Ms. Pratt-Chapman, please contact Lisa Anderson at or 202-270-4841.


About the GW Cancer Center
The George Washington (GW) Cancer Center is a collaboration between the GW Hospital, the GW Medical Faculty Associates, and the GW School of Medicine and Health Sciences to expand GW’s efforts in the fight against cancer. The GW Cancer Center also partners with the Milken Institute School of Public Health at GW, and incorporates all existing cancer-related activities at GW, serving as a platform for future cancer services and research development. Learn more about the GW Cancer Center at

Latest News

March 28, 2023
A new combination drug treatment showed promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.
March 7, 2023
Elmer Huerta, MD, MPH, director of the Cancer Preventorium at the George Washington University Cancer Center, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum.
January 3, 2023
Julie E. Bauman, MD, MPH, director of the GW Cancer Center, associate dean of cancer and professor of medicine, was featured in the article “Cancer Vaccine Hunt Makes Progress, Finally,” by Lisa Jarvis in the Jan. 3 edition of the Washington Post. Bauman discussed the traction MRNA vaccine trials…